{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:49:22Z","timestamp":1789102162404,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5K12DA033312"],"award-info":[{"award-number":["5K12DA033312"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005938"],"award-info":[{"award-number":["U01FD005938"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008935","name":"Center of Excellence in Regulatory Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.drugalcdep.2025.112679","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:06:58Z","timestamp":1747163218000},"page":"112679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study"],"prefix":"10.1016","volume":"273","author":[{"given":"Benjamin A.","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Liberatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Heimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauretta E.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112679_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drugalcdep.2019.03.031","article-title":"The effectiveness of residential treatment services for individuals with substance use disorders: a systematic review","volume":"201","author":"de Andrade","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108003","article-title":"Are we missing opioid-related deaths among people with HIV?","volume":"212","author":"Becker","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112679_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-020-00211-9","article-title":"Merging statewide data in a public\/university collaboration to address opioid use disorder and overdose","volume":"16","author":"Becker","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1377\/hlthaff.2020.00378","article-title":"Admission practices and cost of care for opioid use disorder at residential addiction treatment programs In The US","volume":"40","author":"Beetham","year":"2021","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: a nested case-control study","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112679_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ki.2008.328","article-title":"Survival analysis: time-dependent effects and time-varying risk factors","volume":"74","author":"Dekker","year":"2008","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112679_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13011-022-00480-4","article-title":"The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis","volume":"17","author":"Dickson-Gomez","year":"2022","journal-title":"Subst. Abus. Treat., Prev., Policy"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112679_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib11","unstructured":"Drug Laws and Regulations. Connecticut Department of Consumer Protection. Accessed December 15, 2021, \u3008https:\/\/portal.ct.gov\/DCP\/Drug-Control-Division\/Drug-Control\/Drug-Laws-and-Regulations\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib12","unstructured":"Drug Overdose Monthly Report. Connecticut Department of Public Health. Accessed 2023, 2023. \u3008https:\/\/portal.ct.gov\/-\/media\/DPH\/Injury-and-Violence-Prevention\/Opioid-Overdose-Data\/Monthly-Death-Reports\/2019-March-2023_Drug-Overdose-Deaths-Monthly-Report_Connecticut_updated-on-4-18-2023_Final.pdf\u3009"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Overdose and prescribed opioids: associations among chronic non-cancer pain patients","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib14","unstructured":"Examiner OoCM. Regulations of the commission on medicolegal investigations. \u3008https:\/\/portal.ct.gov\/-\/media\/OCME\/Policies-and-Regulations\/19a401COMLIregscodifiedto10302006pdf.pdf\u3009"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112679_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13011-023-00561-y","article-title":"Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing","volume":"18","author":"Freeman","year":"2023","journal-title":"Subst. Abus. Treat., Prev., Policy"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112679_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/pds.4157","article-title":"Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records","volume":"26","author":"Green","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112679_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109788","article-title":"Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: a statewide analysis","volume":"244","author":"Howell","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112679_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","article-title":"A conceptual model for understanding post-release opioid-related overdose risk","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addict. Sci. Clin. Pr."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108583","article-title":"Identifying individuals with opioid use disorder: validity of international classification of diseases diagnostic codes for opioid use, dependence and abuse","volume":"221","author":"Lagisetty","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112679_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints - Opportunities to predict and prevent opioid overdose: a cohort study","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112679_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann. Intern Med"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112679_bib24","first-page":"Cd002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":";2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib25","first-page":"Cd002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsat.2020.01.017","article-title":"Opioid overdose and inpatient care for substance use disorder care in Massachusetts","volume":"112","author":"Morgan","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108649","article-title":"Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder","volume":"221","author":"Nayak","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib29","unstructured":"New Safety Measures Announced for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepines. U.S. Food and Drug Administration. Accessed February 28, 2024, 2024. \u3008https:\/\/www.fda.gov\/drugs\/information-drug-class\/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib30","unstructured":"Provisional Data Shows U.S. Drug Overdose Deaths Top 100,000 in 2022. NCHS: a blog of the National Center for Health Statistics blog. May 18, 2023, 2023. \u3008https:\/\/blogs.cdc.gov\/nchs\/2023\/05\/18\/7365\/\u3009"},{"issue":"50-51","key":"10.1016\/j.drugalcdep.2025.112679_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112679_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2020.1689","article-title":"Predictive modeling of opioid overdose using linked statewide medical and criminal justice data","volume":"77","author":"Saloner","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112679_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1377\/hlthaff.2021.01767","article-title":"Trends in the use of treatment for substance use disorders, 2010\u201319","volume":"41","author":"Saloner","year":"2022","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2025.112679_bib34","unstructured":"Shintani A.K., Girard Td Fau - Eden S.K., Eden Sk Fau - Arbogast P.G., Arbogast Pg Fau - Moons K.G.M., Moons Kg Fau - Ely E.W., Ely E.W. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. (1530-0293 (Electronic))"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2015.07.002","article-title":"Preferences for aftercare among persons seeking short-term opioid detoxification","volume":"59","author":"Stein","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/03616878-8004910","article-title":"Why policies fail: the illusion of services in the opioid epidemic","volume":"45","author":"Strach","year":"2020","journal-title":"J. Health Polit. Policy Law"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11597520-000000000-00000","article-title":"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals","volume":"72","author":"Tetrault","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M17-2854","article-title":"More beds or more chairs? Using a science-based approach to address the opioid epidemic","volume":"1","author":"Tetrault","year":"2018","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.drugalcdep.2025.112679_bib39","unstructured":"Treatment Episode Data Set. Substance Abuse and Mental Health Services Administration. Accessed December 15, 2021, \u3008https:\/\/www.samhsa.gov\/data\/data-we-collect\/teds-treatment-episode-data-set\u3009"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112679_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112679_bib41","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/add.14964","article-title":"Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis","volume":"115","author":"Walley","year":"2020","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112679_bib42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jama.2020.9151","article-title":"Immortal time bias in observational studies","volume":"325","author":"Yadav","year":"2021","journal-title":"JAMA"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:24:31Z","timestamp":1774869871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625001322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S0376871625001322"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112679","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112679"}}